<h1>Oman to Fast-Track Approval for Indian Pharma Products after India-Oman Joint Commission Meeting in New Delhi.</h1> Oman has agreed to expedite the approval process for Indian pharmaceutical products registered with USFDA, UKMHRA, and EMA, following the 10th India-Oman Joint Commission Meeting in New Delhi. The meeting, co-chaired by Indian and Omani commerce ministers, also highlighted India's appreciation for Oman ratifying the International Solar Alliance and supporting the One Sun One World One Grid initiative. Both nations committed to addressing trade barriers, concluding pending agreements, and enhancing collaboration in various sectors, including renewable energy and pharmaceuticals. Bilateral trade has surged significantly, with Indian investments in Oman reaching $7.5 billion. An invitation was extended for a 2023 meeting in Oman.